Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID-19 pandemic in Belgium [Silversmit et al. 2021]

Excess Mortality in a Nationwide Cohort of Cancer Patients during the Initial Phase of the COVID-19 Pandemic in Belgium [Silversmit et al. 2021]

In a study published in Cancer Epidemiology, Biomarkers, & Prevention, Geert Silversmit and colleagues from the Belgian Cancer Registry, analysed excess mortality in a Belgian cancer cohort during the first wave of the COVID-19 pandemic. They observed considerable excess mortality in the Belgian cancer cohort, but found that the pattern of excess mortality was not markedly different from that observed in the general population.

The publication is available via https://cebp.aacrjournals.org/content/30/9/1615.


HELICON is funded by the Belgian Federal Science Policy (BELSPO) through the BRAIN-be 2.0 (2018-2023) programme.

BRAIN-be logoBELSPO logo

Information sheet for participants: EN • NL • FR

Project coordinator

Prof. dr. Brecht Devleesschauwer

Sciensano, Department of Epidemiology and Public Health, Service Health Information